Comparative Outcomes Study of Metformin Intervention versus Conventional Approach: The COSMIC Approach Study

Diabetes Care

Volumn 28, Issue 3, 2005, Pages 539-543

  Cryer, Dennis R ^a   Nicholas, Savian P ^a   Henry, David H ^a   Mills, Donna J ^a   Stadel, Bruce V ^b  

^a BRISTOL MYERS SQUIBB   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTIDIABETIC AGENT; BIGUANIDE DERIVATIVE; INSULIN; METFORMIN; PHENFORMIN; SULFONYLUREA DERIVATIVE;

ADULT; AGED; ARTICLE; CARDIOTOXICITY; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; COUNSELING; CREATININE CLEARANCE; DIABETES MELLITUS; DIETARY INTAKE; DRUG SAFETY; FEMALE; HEART INFARCTION; HOSPITALIZATION; HUMAN; LACTIC ACIDOSIS; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SIDE EFFECT; THORAX PAIN;

ACIDOSIS, LACTIC; AGED; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; MALE; METFORMIN; MIDDLE AGED; SULFONYLUREA COMPOUNDS; SURVIVAL ANALYSIS;

EID: 14644390253     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.28.3.539     Document Type: Article

References (20)

1. Sirtori CR, Pasik C: Re-evaluation of a biguanide, metformin: mechanism of action and tolerability. Pharmacol Res 30:197-228, 1994
2. Misbin RI, Green L, Stadel BV, Gueriguian JL, Gubbi A, Fleming A: Lactic acidosis in patients with diabetes treated with metformin. N Engl J Med 338:265-266, 1998
3. Stacpoole PW, Wright EC, Baumgartner TG, Bersin RM, Buchalter S, Curry SH, Duncan C, Harman EM, Henderson GN, Jenkinson S, Lachin JM, Lorenz A, Schneider SH, Siegel JH, Summer WR, Thompson D, Wolfe CL, Zorovich B: Natural history and course of acquired lactic acidosis in adults: DCA-Lactic Acidosis Study Group. Am J Med 97:47-54, 1994
4. Blow O, Magliore L, Claridge JA, Butler K, Young JS: The golden hour and the silver day: detection and correction of occult hypoperfusion within 24 hours improves outcome from major trauma. J Trauma 47: 964-969, 1999
5. Misbin RI: Phenformin-associated lactic acidosis: pathogenesis and treatment. Ann Int Med 87:591-595, 1977
6. Krentz AJ, Ferner RE, Bailey CJ: Comparative tolerability profiles of oral antidiabetic agents. Drug Saf 11:223-241, 1994
7. Salpeter S, Greyber E, Pasternak G, Salpeter E: Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Cochrane Database Syst Rev 2:CD002967, 2003
8. Salpeter SR, Greyber E, Pasternak GA, Salpeter EE: Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus: systematic review and meta-analysis. Arch Intern Med 163: 2594-2602, 2003
9. Cavallo-Perin P, Aluffi E, Estivi P, Bruno A, Carta Q, Pagano G, Lenti G: The hyperlactemic effect of biguanides: a comparison between phenformin and metformin during 6-month treatment. Rivisia Europe per le Scienze Mediche e Farmacologische 11:45-49, 1989
10. Kwong SC, Brubacher J: Phenformin and lactic acidosis: a case report and review. J Emerg Med 16:881-886, 1998
11. Bailey CJ: Biguanides and NIDDM. Diabetes Care 15:755-772, 1992
12. McGuinness ME, Talbert RL: Phenformin-induced lactic acidosis: a forgotten adverse drug reaction. Ann Pharmacother 27: 1183-1187, 1993
13. Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Division of Diabetes Translation. Diabetes Surveillance 1999 [article online]. Available at http://www.cdc.gov/ diabetes/statistics/surv199/chap5/table1.htm. Accessed 6 September 2003
14. Brown JB, Pedula K, Barzilay J, Herson MK, Latare P: Lactic acidosis rates in type 2 diabetes. Diabetes Care 21:1659-1663, 1998
15. UK Prospective Diabetes Study Group: Effect of intensive blood glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 352:854-865, 1998
16. Diabetes Prevention Program Research Group: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393-403, 2002
17. Aguilar C, Reza A, Garcia JE, Rull JA: Biguanide related lactic acidosis: incidence and risk factors. Arch Med Res 23:19-24, 1992
18. Lalau J-D, Race J-M: Lactic acidosis in metformin-treated patients: prognostic value of arterial lactate levels and plasma metformin concentrations. Drug Saf 20: 377-384, 1999
19. Huckabee WE: Hyperlactatemia. Helv Med Acta 35:363-376, 1970
20. Stacpoole PW, Harman EM, Curry SH, Baumgartner TG, Misbin RI: Treatment of lactic acidosis with dichloroacetate. N Engl J Med 309:390-396, 1983